Biogen Inc (BIIB)
158.18
+2.18
(+1.40%)
USD |
NASDAQ |
Nov 21, 14:59
Biogen Price: 158.18 for Nov. 21, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 20, 2024 | 155.03 | 156.18 | 153.62 | 156.00 | 1.602M |
| Nov 19, 2024 | 157.02 | 157.90 | 155.28 | 155.43 | 1.297M |
| Nov 18, 2024 | 158.19 | 160.11 | 157.40 | 157.94 | 1.633M |
| Nov 15, 2024 | 165.46 | 166.34 | 159.60 | 159.99 | 1.917M |
| Nov 14, 2024 | 165.00 | 175.86 | 163.35 | 164.89 | 3.211M |
| Nov 13, 2024 | 167.74 | 168.98 | 165.53 | 165.79 | 1.395M |
| Nov 12, 2024 | 171.36 | 171.61 | 167.71 | 168.28 | 1.406M |
| Nov 11, 2024 | 173.92 | 173.92 | 171.11 | 172.03 | 1.458M |
| Nov 08, 2024 | 173.58 | 175.20 | 171.57 | 173.04 | 1.582M |
| Nov 07, 2024 | 175.69 | 176.95 | 172.80 | 173.92 | 1.438M |
| Nov 06, 2024 | 176.87 | 179.20 | 173.66 | 174.40 | 1.828M |
| Nov 05, 2024 | 172.71 | 177.25 | 170.72 | 176.93 | 2.472M |
| Nov 04, 2024 | 173.22 | 174.85 | 170.71 | 173.52 | 2.495M |
| Nov 01, 2024 | 173.65 | 175.99 | 173.14 | 173.79 | 1.456M |
| Oct 31, 2024 | 178.11 | 179.48 | 173.88 | 174.00 | 1.756M |
| Oct 30, 2024 | 184.63 | 185.00 | 177.93 | 181.18 | 1.633M |
| Oct 29, 2024 | 184.82 | 187.28 | 183.19 | 183.47 | 1.343M |
| Oct 28, 2024 | 182.48 | 185.60 | 181.73 | 185.01 | 1.894M |
| Oct 25, 2024 | 185.70 | 187.58 | 181.24 | 181.69 | 1.720M |
| Oct 24, 2024 | 184.79 | 185.72 | 183.28 | 183.86 | 1.057M |
| Oct 23, 2024 | 184.88 | 185.82 | 182.11 | 182.98 | 977680.0 |
| Oct 22, 2024 | 183.81 | 186.54 | 182.80 | 185.90 | 830923.0 |
| Oct 21, 2024 | 190.16 | 190.40 | 184.02 | 184.65 | 1.253M |
| Oct 18, 2024 | 188.22 | 191.19 | 187.94 | 190.16 | 928129.0 |
| Oct 17, 2024 | 188.55 | 190.19 | 187.70 | 189.55 | 728862.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
155.43
Minimum
Nov 19 2024
414.71
Maximum
Jun 10 2021
259.59
Average
265.73
Median
Apr 08 2021
Price Benchmarks
| Eli Lilly and Co | 751.25 |
| Sage Therapeutics Inc | 4.87 |
| Pfizer Inc | 24.94 |
| Amgen Inc | 290.21 |
| Ionis Pharmaceuticals Inc | 33.95 |
Price Related Metrics
| PE Ratio | 14.29 |
| PS Ratio | 2.403 |
| PEG Ratio | 1.423 |
| Price to Book Value | 1.409 |
| Price to Free Cash Flow | 13.05 |
| Earnings Yield | 7.00% |
| Market Cap | 23.05B |
| PEGY Ratio | 1.423 |
| Operating PE Ratio | 10.37 |
| Normalized PE Ratio | 13.38 |